-
1
-
-
0027184593
-
Heart transplantation as a treatment option for end-stage heart disease in patients older than 65 years of age
-
Jul-Aug;
-
Heroux AL, Costanzo-Nordin MR, O'Sullivan JE, et al. Heart transplantation as a treatment option for end-stage heart disease in patients older than 65 years of age. J Heart Lung Transplant 1993 Jul-Aug; 12 (4): 573-8
-
(1993)
J Heart Lung Transplant
, vol.12
, Issue.4
, pp. 573-578
-
-
Heroux, A.L.1
Costanzo-Nordin, M.R.2
O'Sullivan, J.E.3
-
2
-
-
0026785184
-
Heart transplantation in patients over 54 years of age with triple-drug therapy immunosuppression
-
Sep-Oct;
-
Fabbri A, Sharples LD, Mullins P, et al. Heart transplantation in patients over 54 years of age with triple-drug therapy immunosuppression. J Heart Lung Transplant 1992 Sep-Oct; 11 (5): 929-32
-
(1992)
J Heart Lung Transplant
, vol.11
, Issue.5
, pp. 929-932
-
-
Fabbri, A.1
Sharples, L.D.2
Mullins, P.3
-
3
-
-
0023751568
-
Heart transplantation in elderly patients
-
Jul-Aug;
-
Olivari MT, Antolick A, Kaye MP, et al. Heart transplantation in elderly patients. J Heart Transplant 1988 Jul-Aug; 7 (4): 258-64
-
(1988)
J Heart Transplant
, vol.7
, Issue.4
, pp. 258-264
-
-
Olivari, M.T.1
Antolick, A.2
Kaye, M.P.3
-
4
-
-
0042623539
-
Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation
-
Aug;
-
Zuckermann A, Dunkler D, Deviatko E, et al. Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation. Eur J Cardiothorac Surg 2003 Aug; 24 (2): 283-91
-
(2003)
Eur J Cardiothorac Surg
, vol.24
, Issue.2
, pp. 283-291
-
-
Zuckermann, A.1
Dunkler, D.2
Deviatko, E.3
-
5
-
-
0027074886
-
Clinical results of heart transplantation in recipients over 55 years of age with donors over 40 years of age
-
Nov-Dec;
-
Luciani GB, Livi U, Faggian G, et al. Clinical results of heart transplantation in recipients over 55 years of age with donors over 40 years of age. J Heart Lung Transplant 1992 Nov-Dec; 11 (6): 1177-83
-
(1992)
J Heart Lung Transplant
, vol.11
, Issue.6
, pp. 1177-1183
-
-
Luciani, G.B.1
Livi, U.2
Faggian, G.3
-
6
-
-
0030978796
-
Heart transplantation in patients over 54 years of age: Mortality, morbidity and quality of life
-
May;
-
Rickenbacher PR, Lewis NP, Valantine HA, et al. Heart transplantation in patients over 54 years of age: mortality, morbidity and quality of life. Eur Heart J 1997 May; 18 (5): 870-8
-
(1997)
Eur Heart J
, vol.18
, Issue.5
, pp. 870-878
-
-
Rickenbacher, P.R.1
Lewis, N.P.2
Valantine, H.A.3
-
7
-
-
0032772491
-
An analysis of the effect of age on survival after heart transplant
-
Jul;
-
Borkon AM, Muehlebach GF, Jones PG, et al. An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant 1999 Jul; 18 (7): 668-74
-
(1999)
J Heart Lung Transplant
, vol.18
, Issue.7
, pp. 668-674
-
-
Borkon, A.M.1
Muehlebach, G.F.2
Jones, P.G.3
-
8
-
-
0029715994
-
Long-term results of heart transplantation deteriorate more rapidly in patients over 60 years of age
-
Robin J, Ninet J, Tronc F, et al. Long-term results of heart transplantation deteriorate more rapidly in patients over 60 years of age. Eur J Cardiothorac Surg 1996; 10 (4): 259-63
-
(1996)
Eur J Cardiothorac Surg
, vol.10
, Issue.4
, pp. 259-263
-
-
Robin, J.1
Ninet, J.2
Tronc, F.3
-
10
-
-
0042844680
-
Long-term results of heart transplantation in patients older than 60 years
-
Jul;
-
Demers P, Moffatt S, Oyer PE, et al. Long-term results of heart transplantation in patients older than 60 years. J Thorac Cardiovasc Surg 2003 Jul; 126 (1): 224-31
-
(2003)
J Thorac Cardiovasc Surg
, vol.126
, Issue.1
, pp. 224-231
-
-
Demers, P.1
Moffatt, S.2
Oyer, P.E.3
-
11
-
-
0041831167
-
Differential characteristics of heart transplantation in patients older than 60 years
-
Aug;
-
Peraira JR, Segovia J, Fuentes R, et al. Differential characteristics of heart transplantation in patients older than 60 years. Transplant Proc 2003 Aug; 35 (5): 1959-61
-
(2003)
Transplant Proc
, vol.35
, Issue.5
, pp. 1959-1961
-
-
Peraira, J.R.1
Segovia, J.2
Fuentes, R.3
-
12
-
-
0242468952
-
Cardiac transplantation in the older recipient: Excellent long-term survival based on pretransplant screening
-
Nov;
-
Baran DA, Galin ID, Courtney MC, et al. Cardiac transplantation in the older recipient: excellent long-term survival based on pretransplant screening. Transplant Proc 2003 Nov; 35 (7): 2465-7
-
(2003)
Transplant Proc
, vol.35
, Issue.7
, pp. 2465-2467
-
-
Baran, D.A.1
Galin, I.D.2
Courtney, M.C.3
-
13
-
-
9744266676
-
A comparative analysis of outcome after heart transplantation in patients aged 60 years and older: The University of Alberta experience
-
Nov-Dec;
-
Nagendran J, Wildhirt SM, Modry D, et al. A comparative analysis of outcome after heart transplantation in patients aged 60 years and older: the University of Alberta experience. J Card Surg 2004 Nov-Dec; 19 (6): 559-62
-
(2004)
J Card Surg
, vol.19
, Issue.6
, pp. 559-562
-
-
Nagendran, J.1
Wildhirt, S.M.2
Modry, D.3
-
14
-
-
10744220560
-
Long-term results of cardiac transplantation in patients 65 years of age and older: A comparative analysis
-
Dec;
-
Morgan JA, John R, Weinberg AD, et al. Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis. Ann Thorac Surg 2003 Dec; 76 (6): 1982-7
-
(2003)
Ann Thorac Surg
, vol.76
, Issue.6
, pp. 1982-1987
-
-
Morgan, J.A.1
John, R.2
Weinberg, A.D.3
-
15
-
-
27844569484
-
The need for a tailored immunosuppression in older heart transplant recipients
-
Nov;
-
Kaczmarek I, Sadoni S, Schmoeckel M, et al. The need for a tailored immunosuppression in older heart transplant recipients. J Heart Lung Transplant 2005 Nov; 24 (11): 1965-8
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.11
, pp. 1965-1968
-
-
Kaczmarek, I.1
Sadoni, S.2
Schmoeckel, M.3
-
16
-
-
0035071628
-
Heart transplantation in patients seventy years of age and older: A comparative analysis of outcome
-
Mar;
-
Blanche C, Blanche DA, Kearney B, et al. Heart transplantation in patients seventy years of age and older: a comparative analysis of outcome. J Thorac Cardiovasc Surg 2001 Mar; 121 (3): 532-41
-
(2001)
J Thorac Cardiovasc Surg
, vol.121
, Issue.3
, pp. 532-541
-
-
Blanche, C.1
Blanche, D.A.2
Kearney, B.3
-
17
-
-
34547603040
-
Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant report - 2007
-
Aug;
-
Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report - 2007. J Heart Lung Transplant 2007 Aug; 26 (8): 769-81
-
(2007)
J Heart Lung Transplant
, vol.26
, Issue.8
, pp. 769-781
-
-
Taylor, D.O.1
Edwards, L.B.2
Boucek, M.M.3
-
19
-
-
33646779150
-
Long-term results of tacrolimus monotherapy in cardiac transplant recipients
-
Jun;
-
Lubitz SA, Baran DA, Alwarshetty MM, et al. Long-term results of tacrolimus monotherapy in cardiac transplant recipients. J Heart Lung Transplant 2006 Jun; 25 (6): 699-706
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.6
, pp. 699-706
-
-
Lubitz, S.A.1
Baran, D.A.2
Alwarshetty, M.M.3
-
20
-
-
25844439617
-
Aging and the environment: A research framework
-
Geller AM, Zenick H. Aging and the environment: a research framework. Environ Health Perspect 2005; 113 (9): 1257-62
-
(2005)
Environ Health Perspect
, vol.113
, Issue.9
, pp. 1257-1262
-
-
Geller, A.M.1
Zenick, H.2
-
23
-
-
33745767702
-
Long-term cardiovascular risk in transplantation: Insights from the use of everolimus in heart transplantation
-
Jul;
-
Eisen H. Long-term cardiovascular risk in transplantation: insights from the use of everolimus in heart transplantation. Nephrol Dial Transplant 2006 Jul; 21 Suppl. 3: iii9-13
-
(2006)
Nephrol Dial Transplant
, vol.21
, Issue.SUPPL. 3
-
-
Eisen, H.1
-
24
-
-
0037393121
-
Immunosuppressive drugs and cancer
-
Vial T, Descotes J. Immunosuppressive drugs and cancer. Toxicology 2003; 185: 229-40
-
(2003)
Toxicology
, vol.185
, pp. 229-240
-
-
Vial, T.1
Descotes, J.2
-
25
-
-
0035070003
-
Exponentially increased risk of infectious death in older transplant recipients
-
Meier-Krische HU, Ojo A, Hanson J. Exponentially increased risk of infectious death in older transplant recipients. Kidney Int 2001; 59: 1539-43
-
(2001)
Kidney Int
, vol.59
, pp. 1539-1543
-
-
Meier-Krische, H.U.1
Ojo, A.2
Hanson, J.3
-
26
-
-
0028199120
-
Cytomegalovirus infection rate among heart transplant patients in relation to anti-thymocyte immunoglobulin induction therapy: Copenhagen Heart Transplant Group
-
Krogsgaard K, Boesgaard S, Aldershvile J, et al. Cytomegalovirus infection rate among heart transplant patients in relation to anti-thymocyte immunoglobulin induction therapy: Copenhagen Heart Transplant Group. Scand J Infect Dis 1994; 26 (3): 239-47
-
(1994)
Scand J Infect Dis
, vol.26
, Issue.3
, pp. 239-247
-
-
Krogsgaard, K.1
Boesgaard, S.2
Aldershvile, J.3
-
27
-
-
0027501649
-
-
Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993 Dec 18-25; 342 (8886-8887): 1514-6
-
Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993 Dec 18-25; 342 (8886-8887): 1514-6
-
-
-
-
28
-
-
0026348598
-
OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients
-
Nov-Dec;
-
Prieto M, Lake KD, Pritzker MR, et al. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients. J Heart Lung Transplant 1991 Nov-Dec; 10 (6): 901-11
-
(1991)
J Heart Lung Transplant
, vol.10
, Issue.6
, pp. 901-911
-
-
Prieto, M.1
Lake, K.D.2
Pritzker, M.R.3
-
29
-
-
0025213242
-
Prophylactic therapy for rejection after cardiac transplantation: A comparison of rabbit antithymocyte globulin and OKT3
-
Apr;
-
Kirklin JK, Bourge RC, White-Williams C, et al. Prophylactic therapy for rejection after cardiac transplantation: a comparison of rabbit antithymocyte globulin and OKT3. J Thorac Cardiovasc Surg 1990 Apr; 99 (4): 716-24
-
(1990)
J Thorac Cardiovasc Surg
, vol.99
, Issue.4
, pp. 716-724
-
-
Kirklin, J.K.1
Bourge, R.C.2
White-Williams, C.3
-
30
-
-
0027391180
-
A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation: Increased morbidity with OKT3
-
Jan;
-
Macdonald PS, Mundy J, Keogh AM, et al. A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation: increased morbidity with OKT3. Transplantation 1993 Jan; 55 (1): 110-6
-
(1993)
Transplantation
, vol.55
, Issue.1
, pp. 110-116
-
-
Macdonald, P.S.1
Mundy, J.2
Keogh, A.M.3
-
31
-
-
0034657283
-
-
Zuckermann AO, Grimm M, Czerny M, et al. Improved long-term results with thymoglobulin induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulins. Transplantation 2000 May 15; 69 (9): 1890-8
-
Zuckermann AO, Grimm M, Czerny M, et al. Improved long-term results with thymoglobulin induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulins. Transplantation 2000 May 15; 69 (9): 1890-8
-
-
-
-
32
-
-
0032738939
-
A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation
-
Dec;
-
Carrier M, White M, Perrault LP, et al. A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation. J Heart Lung Transplant 1999 Dec; 18 (12): 1218-23
-
(1999)
J Heart Lung Transplant
, vol.18
, Issue.12
, pp. 1218-1223
-
-
Carrier, M.1
White, M.2
Perrault, L.P.3
-
33
-
-
13444311969
-
Use of basiliximab and cyclosporine in heart transplant patients with preoperative renal dysfunction
-
Feb;
-
Delgado DH, Miriuka SG, Cusimano RJ, et al. Use of basiliximab and cyclosporine in heart transplant patients with preoperative renal dysfunction. J Heart Lung Transplant 2005 Feb; 24 (2): 166-9
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.2
, pp. 166-169
-
-
Delgado, D.H.1
Miriuka, S.G.2
Cusimano, R.J.3
-
34
-
-
33748162571
-
Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus antithymocyte globulin as induction therapy after heart transplantation
-
Sep;
-
Bonaros N, Dunkler D, Kocher A, et al. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus antithymocyte globulin as induction therapy after heart transplantation. J Heart Lung Transplant 2006 Sep; 25 (9): 1154-63
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.9
, pp. 1154-1163
-
-
Bonaros, N.1
Dunkler, D.2
Kocher, A.3
-
35
-
-
4544325560
-
Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction
-
Sep 15;
-
Cantarovich M, Giannetti N, Barkun J, et al. Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction. Transplantation 2004 Sep 15; 78 (5): 779-81
-
(2004)
Transplantation
, vol.78
, Issue.5
, pp. 779-781
-
-
Cantarovich, M.1
Giannetti, N.2
Barkun, J.3
-
36
-
-
85036986309
-
-
Zuckermann A, Dunkler D, Haidbauer B, et al. Thymoglobulin induction therapy creates excellent long-term outcome in patients with positive lymphocyte crossmatch after cardiac transplantation [abstract]. American Transplant Congress; 2004 May 15-19; Boston (MA). Am J Transplant 2004 Mar; 4 Suppl. 8: 65S
-
Zuckermann A, Dunkler D, Haidbauer B, et al. Thymoglobulin induction therapy creates excellent long-term outcome in patients with positive lymphocyte crossmatch after cardiac transplantation [abstract]. American Transplant Congress; 2004 May 15-19; Boston (MA). Am J Transplant 2004 Mar; 4 Suppl. 8: 65S
-
-
-
-
37
-
-
0035993796
-
Low incidence of graft arteriosclerosis after cardiac transplantation: Risk factor analysis for patients with induction therapy
-
Aug;
-
Zuckermann A, Ploner M, Czerny M, et al. Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy. Transplant Proc 2002 Aug; 34 (5): 1869-71
-
(2002)
Transplant Proc
, vol.34
, Issue.5
, pp. 1869-1871
-
-
Zuckermann, A.1
Ploner, M.2
Czerny, M.3
-
38
-
-
34250777773
-
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
-
Jul;
-
Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 2007 Jul; 21 (7): 1387-94
-
(2007)
Leukemia
, vol.21
, Issue.7
, pp. 1387-1394
-
-
Mohty, M.1
-
39
-
-
1342304173
-
Lymphomas after solid organ transplantation: A collaborative transplant study report
-
Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2003; 4: 222-30
-
(2003)
Am J Transplant
, vol.4
, pp. 222-230
-
-
Opelz, G.1
Döhler, B.2
-
40
-
-
28444449100
-
Incidence and prognosis of cancer following heart transplantation using ATG induction therapy
-
El-Hamamsay I, Stevens LM, Carrier M, et al. Incidence and prognosis of cancer following heart transplantation using ATG induction therapy. Transpl Int 2005; 18 (11): 1280-5
-
(2005)
Transpl Int
, vol.18
, Issue.11
, pp. 1280-1285
-
-
El-Hamamsay, I.1
Stevens, L.M.2
Carrier, M.3
-
41
-
-
0034594886
-
Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody
-
Mar 2;
-
Beniaminovitz A, Itescu S, Lietz K, et al. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med 2000 Mar 2; 342 (9): 613-9
-
(2000)
N Engl J Med
, vol.342
, Issue.9
, pp. 613-619
-
-
Beniaminovitz, A.1
Itescu, S.2
Lietz, K.3
-
42
-
-
24344508163
-
A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation
-
Sep;
-
Mehra MR, Zucker MJ, Wagoner L, et al. A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation. J Heart Lung Transplant 2005 Sep; 24 (9): 1297-304
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.9
, pp. 1297-1304
-
-
Mehra, M.R.1
Zucker, M.J.2
Wagoner, L.3
-
43
-
-
21244490121
-
Daclizumab to prevent rejection after cardiac transplantation
-
Jun 30;
-
Hershberger RE, Starling RC, Eisen HJ, et al. Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med 2005 Jun 30; 352 (26): 2705-13
-
(2005)
N Engl J Med
, vol.352
, Issue.26
, pp. 2705-2713
-
-
Hershberger, R.E.1
Starling, R.C.2
Eisen, H.J.3
-
44
-
-
33745159699
-
A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study
-
Jun 15;
-
Segovia J, Rodriguez-Lambert JL, Crespo-Leiro MG, et al. A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study. Transplantation 2006 Jun 15; 81 (11): 1542-8
-
(2006)
Transplantation
, vol.81
, Issue.11
, pp. 1542-1548
-
-
Segovia, J.1
Rodriguez-Lambert, J.L.2
Crespo-Leiro, M.G.3
-
45
-
-
0027462585
-
Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies
-
Apr;
-
Norman DJ, Chatenoud L, Cohen D, et al. Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies. Transplant Proc 1993 Apr; 25 (2 Suppl. 1): 89-92
-
(1993)
Transplant Proc
, vol.25
, Issue.2 SUPPL. 1
, pp. 89-92
-
-
Norman, D.J.1
Chatenoud, L.2
Cohen, D.3
-
46
-
-
0029887271
-
A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation
-
Jul 15;
-
van Gelder T, Balk AH, Jonkman FA, et al. A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation. Transplantation 1996 Jul 15; 62 (1): 51-5
-
(1996)
Transplantation
, vol.62
, Issue.1
, pp. 51-55
-
-
van Gelder, T.1
Balk, A.H.2
Jonkman, F.A.3
-
47
-
-
0025661946
-
Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients
-
Dec 20;
-
Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990 Dec 20; 323 (25): 1723-8
-
(1990)
N Engl J Med
, vol.323
, Issue.25
, pp. 1723-1728
-
-
Swinnen, L.J.1
Costanzo-Nordin, M.R.2
Fisher, S.G.3
-
48
-
-
0027969105
-
Cardiac transplantation: The Stanford experience in the cyclosporine era
-
Sarris GE, Moore KA, Schroeder JS, et al. Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg 1994; 108: 240-5
-
(1994)
J Thorac Cardiovasc Surg
, vol.108
, pp. 240-245
-
-
Sarris, G.E.1
Moore, K.A.2
Schroeder, J.S.3
-
49
-
-
0032954561
-
Thirty years of cardiac transplantation at Stanford University
-
Robbins R, Barlow C, Oyer P, et al. Thirty years of cardiac transplantation at Stanford University. J Thorac Cardiovasc Surg 1999; 117: 939-44
-
(1999)
J Thorac Cardiovasc Surg
, vol.117
, pp. 939-944
-
-
Robbins, R.1
Barlow, C.2
Oyer, P.3
-
50
-
-
0031035801
-
Renal function in cardiac transplant recipients: Retrospective analysis of 13 consecutive patients in a single center
-
Tinawi M, Miller L, Bastani B. Renal function in cardiac transplant recipients: retrospective analysis of 13 consecutive patients in a single center. Clin Transplant 1997; 11 (1): 1-8
-
(1997)
Clin Transplant
, vol.11
, Issue.1
, pp. 1-8
-
-
Tinawi, M.1
Miller, L.2
Bastani, B.3
-
51
-
-
0030845767
-
Cyclosporin nephrotoxicity following cardiac transplantation
-
Woolfson RG, Neild GH. Cyclosporin nephrotoxicity following cardiac transplantation. Nephrol Dial Transplant 1997; 12: 2054-6
-
(1997)
Nephrol Dial Transplant
, vol.12
, pp. 2054-2056
-
-
Woolfson, R.G.1
Neild, G.H.2
-
52
-
-
0024237509
-
Chronic injury of human renal microvessels with low-dose cyclosporine therapy
-
Myers BD, Newton L, Boshkos C, et al. Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 1988; 46 (5): 694-703
-
(1988)
Transplantation
, vol.46
, Issue.5
, pp. 694-703
-
-
Myers, B.D.1
Newton, L.2
Boshkos, C.3
-
53
-
-
0030898964
-
Cyclosporine-associated end-stage nephropathy after cardiac transplantation: Incidence and progression
-
Goldstein DJ, Zuech N, Sehgal V, et al. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 1997; 63 (5): 664-8
-
(1997)
Transplantation
, vol.63
, Issue.5
, pp. 664-668
-
-
Goldstein, D.J.1
Zuech, N.2
Sehgal, V.3
-
54
-
-
0030966728
-
Cardiac allograft rejection: Do trough cyclosporine levels correlate with the grade of histologic rejection?
-
El Gamel A, Keevil B, Rahman A, et al. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection? J Heart Lung Transplant 1997; 16 (3): 268-74
-
(1997)
J Heart Lung Transplant
, vol.16
, Issue.3
, pp. 268-274
-
-
El Gamel, A.1
Keevil, B.2
Rahman, A.3
-
55
-
-
0030679675
-
Long-term renal function in heart transplant recipients receiving cyclosporine therapy
-
Goral S, Ynares C, Shyr Y, et al. Long-term renal function in heart transplant recipients receiving cyclosporine therapy. J Heart Lung Transplant 1997; 16 (11): 1106-12
-
(1997)
J Heart Lung Transplant
, vol.16
, Issue.11
, pp. 1106-1112
-
-
Goral, S.1
Ynares, C.2
Shyr, Y.3
-
56
-
-
0036753579
-
Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil
-
Tedoriya T, Keogh AM, Kusano K, et al. Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil. J Heart Lung Transplant 2002; 21 (9): 976-82
-
(2002)
J Heart Lung Transplant
, vol.21
, Issue.9
, pp. 976-982
-
-
Tedoriya, T.1
Keogh, A.M.2
Kusano, K.3
-
57
-
-
0011236968
-
Benefit of mycophenolate- mofetil (MMF) in patients with cyclosporine (CyA) induced nephropathy after cardiac transplantation [abstract]
-
Zuckermann A, Ploner M, Keziban U, et al. Benefit of mycophenolate- mofetil (MMF) in patients with cyclosporine (CyA) induced nephropathy after cardiac transplantation [abstract]. J Heart Lung Transplant 2001; 20 (2): 163
-
(2001)
J Heart Lung Transplant
, vol.20
, Issue.2
, pp. 163
-
-
Zuckermann, A.1
Ploner, M.2
Keziban, U.3
-
58
-
-
0036253476
-
Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment
-
Snell GI, Levvey BJ, Chin W, et al. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 2002; 21 (5): 540-6
-
(2002)
J Heart Lung Transplant
, vol.21
, Issue.5
, pp. 540-546
-
-
Snell, G.I.1
Levvey, B.J.2
Chin, W.3
-
59
-
-
1542719221
-
Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients
-
Mar;
-
Grötzner J, Kaczmarek I, Landwehr P, et al. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients. Eur J Cardiothorac Surg 2004 Mar; 25 (3): 333-41
-
(2004)
Eur J Cardiothorac Surg
, vol.25
, Issue.3
, pp. 333-341
-
-
Grötzner, J.1
Kaczmarek, I.2
Landwehr, P.3
-
60
-
-
85036973389
-
Sirolimus as rescue therapy in heart transplant recipients with calcineurin induced renal dysfunction [abstract]. American Transplant Congress; 2003 May 30-Jun 4; Washington, DC
-
Zuckermann A, Bodhjalian A, Roedler S, et al. Sirolimus as rescue therapy in heart transplant recipients with calcineurin induced renal dysfunction [abstract]. American Transplant Congress; 2003 May 30-Jun 4; Washington, DC. Am J Transplant 2003; 3 Suppl. 5: 61S
-
(2003)
Am J Transplant
, vol.3
, Issue.SUPPL. 5
-
-
Zuckermann, A.1
Bodhjalian, A.2
Roedler, S.3
-
61
-
-
0030753168
-
Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine
-
Ventura HO, Malik FS, Mehra MR, et al. Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 1997; 12 (4): 375-81
-
(1997)
Curr Opin Cardiol
, vol.12
, Issue.4
, pp. 375-381
-
-
Ventura, H.O.1
Malik, F.S.2
Mehra, M.R.3
-
62
-
-
0029119711
-
Effect of pravastatin on outcomes after cardiac transplantation
-
Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333 (10): 621-7
-
(1995)
N Engl J Med
, vol.333
, Issue.10
, pp. 621-627
-
-
Kobashigawa, J.A.1
Katznelson, S.2
Laks, H.3
-
63
-
-
27844521938
-
Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients
-
Nov;
-
Kobashigawa JA, Moriguchi JD, Laks H, et al. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J Heart Lung Transplant 2005 Nov; 24 (11): 1736-40
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.11
, pp. 1736-1740
-
-
Kobashigawa, J.A.1
Moriguchi, J.D.2
Laks, H.3
-
65
-
-
33646763869
-
Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients
-
Jun;
-
Schubert S, Abdul-Khaliq H, Lehmkuhl HB, et al. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients. J Heart Lung Transplant 2006 Jun; 25 (6): 619-25
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.6
, pp. 619-625
-
-
Schubert, S.1
Abdul-Khaliq, H.2
Lehmkuhl, H.B.3
-
66
-
-
33646123088
-
Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation
-
May;
-
Barnard JB, Thekkudan J, Richardson S, et al. Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation. J Heart Lung Transplant 2006 May; 25 (5): 564-8
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.5
, pp. 564-568
-
-
Barnard, J.B.1
Thekkudan, J.2
Richardson, S.3
-
67
-
-
29144516668
-
A randomized, controlled trial of C0- vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients
-
Dec;
-
Mathias HC, Ozalp F, Will MB, et al. A randomized, controlled trial of C0- vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients. J Heart Lung Transplant 2005 Dec; 24 (12): 2137-43
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.12
, pp. 2137-2143
-
-
Mathias, H.C.1
Ozalp, F.2
Will, M.B.3
-
68
-
-
0031682091
-
European Multicenter Tacrolimus (FK506) Heart Pilot Study: One-year results. European Tacrolimus Multicenter Heart Study Group
-
Aug;
-
Reichart B, Meiser B, Vigano M, et al. European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results. European Tacrolimus Multicenter Heart Study Group. J Heart Lung Transplant 1998 Aug; 17 (8): 775-81
-
(1998)
J Heart Lung Transplant
, vol.17
, Issue.8
, pp. 775-781
-
-
Reichart, B.1
Meiser, B.2
Vigano, M.3
-
69
-
-
0032913084
-
A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus
-
Apr;
-
Taylor DO, Barr ML, Radovancevic B, et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999 Apr; 18 (4): 336-45
-
(1999)
J Heart Lung Transplant
, vol.18
, Issue.4
, pp. 336-345
-
-
Taylor, D.O.1
Barr, M.L.2
Radovancevic, B.3
-
70
-
-
0000258596
-
European Multicenter Tacrolimus Heart Pilot Study: Three year follow-up
-
Feb;
-
Reichart B, Meiser B, Vigano M, et al. European Multicenter Tacrolimus Heart Pilot Study: three year follow-up. J Heart Lung Transplant 2001 Feb; 20 (2): 249-50
-
(2001)
J Heart Lung Transplant
, vol.20
, Issue.2
, pp. 249-250
-
-
Reichart, B.1
Meiser, B.2
Vigano, M.3
-
71
-
-
33645076062
-
Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients
-
Apr;
-
Kobashigawa JA, Patel J, Furukawa H, et al. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant 2006 Apr; 25 (4): 434-9
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.4
, pp. 434-439
-
-
Kobashigawa, J.A.1
Patel, J.2
Furukawa, H.3
-
72
-
-
33745833087
-
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients: A large European trial
-
Jun;
-
Grimm M, Rinaldi M, Yonan NA, et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients: a large European trial. Am J Transplant 2006 Jun; 6 (6): 1387-97
-
(2006)
Am J Transplant
, vol.6
, Issue.6
, pp. 1387-1397
-
-
Grimm, M.1
Rinaldi, M.2
Yonan, N.A.3
-
73
-
-
33745393847
-
Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report
-
Jun;
-
Kobashigawa JA, Miller LW, Russell SD, et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 2006 Jun; 6 (6): 1377-86
-
(2006)
Am J Transplant
, vol.6
, Issue.6
, pp. 1377-1386
-
-
Kobashigawa, J.A.1
Miller, L.W.2
Russell, S.D.3
-
74
-
-
0032947542
-
Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: Importance of mycophenolic acid therapeutic drug monitoring
-
Feb;
-
Meiser BM, Pfeiffer M, Schmidt D, et al. Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring. J Heart Lung Transplant 1999 Feb; 18 (2): 143-9
-
(1999)
J Heart Lung Transplant
, vol.18
, Issue.2
, pp. 143-149
-
-
Meiser, B.M.1
Pfeiffer, M.2
Schmidt, D.3
-
75
-
-
4143150741
-
Tacrolimus or cyclosporine: Which is the better partner for mycophenolate mofetil in heart transplant recipients?
-
Aug 27;
-
Meiser BM, Groetzner J, Kaczmarek I, et al. Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Transplantation 2004 Aug 27; 78 (4): 591-8
-
(2004)
Transplantation
, vol.78
, Issue.4
, pp. 591-598
-
-
Meiser, B.M.1
Groetzner, J.2
Kaczmarek, I.3
-
76
-
-
0030755483
-
Tacrolimus: A superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation
-
Aug;
-
Meiser BM, Uberfuhr P, Fuchs A, et al. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation. J Heart Lung Transplant 1997 Aug; 16 (8): 795-800
-
(1997)
J Heart Lung Transplant
, vol.16
, Issue.8
, pp. 795-800
-
-
Meiser, B.M.1
Uberfuhr, P.2
Fuchs, A.3
-
77
-
-
0032988640
-
Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients
-
May;
-
Onsager DR, Canver CC, Jahania MS, et al. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. J Heart Lung Transplant 1999 May; 18 (5): 448-55
-
(1999)
J Heart Lung Transplant
, vol.18
, Issue.5
, pp. 448-455
-
-
Onsager, D.R.1
Canver, C.C.2
Jahania, M.S.3
-
78
-
-
0034041825
-
Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection
-
Apr;
-
Yamani MH, Starling RC, Pelegrin D, et al. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection. J Heart Lung Transplant 2000 Apr; 19 (4): 337-42
-
(2000)
J Heart Lung Transplant
, vol.19
, Issue.4
, pp. 337-342
-
-
Yamani, M.H.1
Starling, R.C.2
Pelegrin, D.3
-
79
-
-
20244388105
-
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients: Mycophenolate Mofetil Investigators
-
Aug 27;
-
Kobashigawa J, Miller L, Renlund D, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients: Mycophenolate Mofetil Investigators. Transplantation 1998 Aug 27; 66 (4): 507-15
-
(1998)
Transplantation
, vol.66
, Issue.4
, pp. 507-515
-
-
Kobashigawa, J.1
Miller, L.2
Renlund, D.3
-
80
-
-
33749507195
-
Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: Analysis of the transplant registry of the International Society for Heart and Lung Transplantation
-
Oct;
-
O'Neill JO, Edwards LB, Taylor DO. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006 Oct; 25 (10): 1186-91
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.10
, pp. 1186-1191
-
-
O'Neill, J.O.1
Edwards, L.B.2
Taylor, D.O.3
-
81
-
-
0029555832
-
Hepatotoxicity of transplant immunosuppressive agents
-
Dec;
-
Kowdley KV, Keeffe EB. Hepatotoxicity of transplant immunosuppressive agents. Gastroenterol Clin North Am 1995 Dec; 24 (4): 991-1001
-
(1995)
Gastroenterol Clin North Am
, vol.24
, Issue.4
, pp. 991-1001
-
-
Kowdley, K.V.1
Keeffe, E.B.2
-
82
-
-
21044458269
-
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients
-
May;
-
Eisen HJ, Kobashigawa J, Keogh A, et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant 2005 May; 24 (5): 517-25
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.5
, pp. 517-525
-
-
Eisen, H.J.1
Kobashigawa, J.2
Keogh, A.3
-
83
-
-
33745261588
-
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: Reanalysis of the multicenter trial
-
May;
-
Kobashigawa JA, Tobis JM, Mentzer RM, et al. Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial. Am J Transplant 2006 May; 6 (5 Pt 1): 993-7
-
(2006)
Am J Transplant
, vol.6
, Issue.5 PART 1
, pp. 993-997
-
-
Kobashigawa, J.A.1
Tobis, J.M.2
Mentzer, R.M.3
-
84
-
-
20844432212
-
Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients: The IMPROVED multi-centre study
-
Sep;
-
Angermann CE, Stork S, Costard-Jackle A, et al. Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients: the IMPROVED multi-centre study. Eur Heart J 2004 Sep; 25 (18): 1626-34
-
(2004)
Eur Heart J
, vol.25
, Issue.18
, pp. 1626-1634
-
-
Angermann, C.E.1
Stork, S.2
Costard-Jackle, A.3
-
85
-
-
10744231167
-
Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure
-
Feb 27;
-
Groetzner J, Meiser B, Landwehr P, et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 2004 Feb 27; 77 (4): 568-74
-
(2004)
Transplantation
, vol.77
, Issue.4
, pp. 568-574
-
-
Groetzner, J.1
Meiser, B.2
Landwehr, P.3
-
86
-
-
29144480970
-
Sirolimus in cardiac transplantation: Use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity
-
Dec;
-
Kushwaha SS, Khalpey Z, Frantz RP, et al. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant 2005 Dec; 24 (12): 2129-36
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.12
, pp. 2129-2136
-
-
Kushwaha, S.S.1
Khalpey, Z.2
Frantz, R.P.3
-
87
-
-
0032811642
-
Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine
-
Aug;
-
Taylor DO, Sharma RC, Kfoury AG, et al. Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine. Clin Transplant 1999 Aug; 13 (4): 296-9
-
(1999)
Clin Transplant
, vol.13
, Issue.4
, pp. 296-299
-
-
Taylor, D.O.1
Sharma, R.C.2
Kfoury, A.G.3
-
88
-
-
0034660341
-
The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection
-
Jun 15;
-
Yamani MH, Starling RC, Goormastic M, et al. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. Transplantation 2000 Jun 15; 69 (11): 2326-30
-
(2000)
Transplantation
, vol.69
, Issue.11
, pp. 2326-2330
-
-
Yamani, M.H.1
Starling, R.C.2
Goormastic, M.3
-
89
-
-
33746473566
-
Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, Myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: Results of a 12-month, single-blind, randomized, parallel-group, multicenter study
-
Aug;
-
Kobashigawa JA, Renlund DG, Gerosa G, et al. Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, Myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study. J Heart Lung Transplant 2006 Aug; 25 (8): 935-41
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.8
, pp. 935-941
-
-
Kobashigawa, J.A.1
Renlund, D.G.2
Gerosa, G.3
-
90
-
-
0034082485
-
The use of mycophenolate mofetil in transplant recipients
-
May;
-
Mele TS, Halloran PF. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000 May; 47 (2-3): 215-45
-
(2000)
Immunopharmacology
, vol.47
, Issue.2-3
, pp. 215-245
-
-
Mele, T.S.1
Halloran, P.F.2
-
91
-
-
23744467925
-
Sirolimus: The evidence for clinical pharmacokinetic monitoring
-
Stenton SB, Partovi N, Ensom MH. Sirolimus: the evidence for clinical pharmacokinetic monitoring. Clin Pharmacokinet 2005; 44 (8): 769-86
-
(2005)
Clin Pharmacokinet
, vol.44
, Issue.8
, pp. 769-786
-
-
Stenton, S.B.1
Partovi, N.2
Ensom, M.H.3
-
92
-
-
26444567404
-
The role of therapeutic monitoring of everolimus in solid organ transplantation
-
Oct;
-
Mabasa VH, Ensom MH. The role of therapeutic monitoring of everolimus in solid organ transplantation. Ther Drug Monit 2005 Oct; 27 (5): 666-76
-
(2005)
Ther Drug Monit
, vol.27
, Issue.5
, pp. 666-676
-
-
Mabasa, V.H.1
Ensom, M.H.2
-
93
-
-
20844461132
-
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial
-
Oct 26;
-
Keogh A, Richardson M, Ruygrok P, et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 2004 Oct 26; 110 (17): 2694-700
-
(2004)
Circulation
, vol.110
, Issue.17
, pp. 2694-2700
-
-
Keogh, A.1
Richardson, M.2
Ruygrok, P.3
-
94
-
-
33745288559
-
Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients
-
May;
-
Kuppahally S, Al-Khaldi A, Weisshaar D, et al. Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Am J Transplant 2006 May; 6 (5 Pt 1): 986-92
-
(2006)
Am J Transplant
, vol.6
, Issue.5 PART 1
, pp. 986-992
-
-
Kuppahally, S.1
Al-Khaldi, A.2
Weisshaar, D.3
-
95
-
-
0038300674
-
Use of rapamycin slows progression of cardiac transplantation vasculopathy
-
Jul 8;
-
Mancini D, Pinney S, Burkhoff D, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003 Jul 8; 108 (1): 48-53
-
(2003)
Circulation
, vol.108
, Issue.1
, pp. 48-53
-
-
Mancini, D.1
Pinney, S.2
Burkhoff, D.3
-
97
-
-
34547592986
-
Development of proteinuria after switch to sirolimus based immunosuppression in long-term cardiac transplant patients [abstract]. World Transplant Congress 2006 poster abstracts
-
Aliabadi AZ, Kammerstätter DP, Seebacher G, et al. Development of proteinuria after switch to sirolimus based immunosuppression in long-term cardiac transplant patients [abstract]. World Transplant Congress 2006 poster abstracts. Am J Transplant 2006; 6 Suppl. 2: 562
-
(2006)
Am J Transplant
, vol.6
, Issue.SUPPL. 2
, pp. 562
-
-
Aliabadi, A.Z.1
Kammerstätter, D.P.2
Seebacher, G.3
-
98
-
-
20344377982
-
Kaposi sarcoma in solid organ transplant recipients: A single center report
-
May;
-
Boeckle E, Boesmueller C, Wiesmayr S, et al. Kaposi sarcoma in solid organ transplant recipients: a single center report. Transplant Proc 2005 May; 37 (4): 1905-9
-
(2005)
Transplant Proc
, vol.37
, Issue.4
, pp. 1905-1909
-
-
Boeckle, E.1
Boesmueller, C.2
Wiesmayr, S.3
-
100
-
-
19244366021
-
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
-
Aug 28;
-
Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003 Aug 28; 349 (9): 847-58
-
(2003)
N Engl J Med
, vol.349
, Issue.9
, pp. 847-858
-
-
Eisen, H.J.1
Tuzcu, E.M.2
Dorent, R.3
-
101
-
-
0141433268
-
Everolimus in de novo cardiac transplantation: Pharmacokinetics, therapeutic range, and influence on cyclosporine exposure
-
Oct;
-
Kovarik JM, Eisen H, Dorent R, et al. Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure. J Heart Lung Transplant 2003 Oct; 22 (10): 1117-25
-
(2003)
J Heart Lung Transplant
, vol.22
, Issue.10
, pp. 1117-1125
-
-
Kovarik, J.M.1
Eisen, H.2
Dorent, R.3
-
102
-
-
15044365786
-
-
Hummel M. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference. J Heart Lung Transplant 2005 Apr; 24 (4 Suppl.): S196-200
-
Hummel M. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference. J Heart Lung Transplant 2005 Apr; 24 (4 Suppl.): S196-200
-
-
-
-
104
-
-
16244380792
-
Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients
-
Apr;
-
Opelz G, Dohler B, Laux G, et al. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005 Apr; 5 (4 Pt 1): 720-8
-
(2005)
Am J Transplant
, vol.5
, Issue.4 PART 1
, pp. 720-728
-
-
Opelz, G.1
Dohler, B.2
Laux, G.3
-
105
-
-
33746210045
-
Effects of early steroid withdrawal after heart transplantation
-
Aug;
-
Rosenbaum DH, Adams BC, Mitchell JD, et al. Effects of early steroid withdrawal after heart transplantation. Ann Thorac Surg 2006 Aug; 82 (2): 637-44
-
(2006)
Ann Thorac Surg
, vol.82
, Issue.2
, pp. 637-644
-
-
Rosenbaum, D.H.1
Adams, B.C.2
Mitchell, J.D.3
-
106
-
-
33748138829
-
Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients
-
Sep;
-
Kobashigawa JA, Starling RC, Mehra MR, et al. Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. J Heart Lung Transplant 2006 Sep; 25 (9): 1063-9
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.9
, pp. 1063-1069
-
-
Kobashigawa, J.A.1
Starling, R.C.2
Mehra, M.R.3
-
107
-
-
0024400666
-
Cyclosporine and azathioprine immunosuppression without maintenance steroids: A prospective randomized trial
-
May-Jun;
-
Esmore DS, Spratt PM, Keogh AM, et al. Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospective randomized trial. J Heart Transplant 1989 May-Jun; 8 (3): 194-9
-
(1989)
J Heart Transplant
, vol.8
, Issue.3
, pp. 194-199
-
-
Esmore, D.S.1
Spratt, P.M.2
Keogh, A.M.3
-
108
-
-
0025764723
-
Cardiac transplantation with corticosteroid-free immunosuppression: Long-term results
-
Aug;
-
Lee KF, Pierce JD, Hess ML, et al. Cardiac transplantation with corticosteroid-free immunosuppression: long-term results. Ann Thorac Surg 1991 Aug; 52 (2): 211-7
-
(1991)
Ann Thorac Surg
, vol.52
, Issue.2
, pp. 211-217
-
-
Lee, K.F.1
Pierce, J.D.2
Hess, M.L.3
-
109
-
-
0023188910
-
Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation
-
Mar-Apr;
-
Renlund DG, O'Connell JB, Gilbert EM, et al. Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation. J Heart Transplant 1987 Mar-Apr; 6 (2): 71-8
-
(1987)
J Heart Transplant
, vol.6
, Issue.2
, pp. 71-78
-
-
Renlund, D.G.1
O'Connell, J.B.2
Gilbert, E.M.3
-
110
-
-
0026720376
-
Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation
-
May-Jun;
-
Keogh A, Macdonald P, Mundy J, et al. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation. J Heart Lung Transplant 1992 May-Jun; 11 (3 Pt 1): 550-5
-
(1992)
J Heart Lung Transplant
, vol.11
, Issue.3 PART 1
, pp. 550-555
-
-
Keogh, A.1
Macdonald, P.2
Mundy, J.3
-
111
-
-
0036242931
-
Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy
-
May;
-
Felkel TO, Smith AL, Reichenspurner HC, et al. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy. J Heart Lung Transplant 2002 May; 21 (5): 530-9
-
(2002)
J Heart Lung Transplant
, vol.21
, Issue.5
, pp. 530-539
-
-
Felkel, T.O.1
Smith, A.L.2
Reichenspurner, H.C.3
-
112
-
-
33745183288
-
Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation
-
Jun;
-
Lubitz SA, Baran DA, Alwarshetty MM, et al. Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation. Transplant Proc 2006 Jun; 38 (5): 1501-6
-
(2006)
Transplant Proc
, vol.38
, Issue.5
, pp. 1501-1506
-
-
Lubitz, S.A.1
Baran, D.A.2
Alwarshetty, M.M.3
-
113
-
-
0033118312
-
Immunosenescence: Impact in the young as well as the old?
-
Apr 1;
-
Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 1999 Apr 1; 108 (1): 1-7
-
(1999)
Mech Ageing Dev
, vol.108
, Issue.1
, pp. 1-7
-
-
Pawelec, G.1
-
114
-
-
0034458563
-
Clinical relevance of age-related immune dysfunction
-
Aug;
-
Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000 Aug; 31 (2): 578-85
-
(2000)
Clin Infect Dis
, vol.31
, Issue.2
, pp. 578-585
-
-
Castle, S.C.1
-
115
-
-
0036345218
-
Rejection and recipient age
-
Aug;
-
Bradley BA. Rejection and recipient age. Transpl Immunol 2002 Aug; 10 (2-3): 125-32
-
(2002)
Transpl Immunol
, vol.10
, Issue.2-3
, pp. 125-132
-
-
Bradley, B.A.1
-
116
-
-
1942469969
-
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
-
Apr;
-
Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004 Apr; 4 (4): 611-20
-
(2004)
Am J Transplant
, vol.4
, Issue.4
, pp. 611-620
-
-
Paya, C.1
Humar, A.2
Dominguez, E.3
-
117
-
-
0035865243
-
Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation
-
Feb 15;
-
Camargo LF, Uip DE, Simpson AA, et al. Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation. Transplantation 2001 Feb 15; 71 (3): 412-7
-
(2001)
Transplantation
, vol.71
, Issue.3
, pp. 412-417
-
-
Camargo, L.F.1
Uip, D.E.2
Simpson, A.A.3
-
118
-
-
33749526844
-
Prevalence of metabolic syndrome in heart transplant patients: Role of previous cardiopathy and years since the procedure: the TRACA study
-
Oct;
-
Cordero Fort A, Gavira JJ, Alegría-Barrero E, et al. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure: the TRACA study. J Heart Lung Transplant 2006 Oct; 25 (10): 1192-8
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.10
, pp. 1192-1198
-
-
Cordero Fort, A.1
Gavira, J.J.2
Alegría-Barrero, E.3
-
119
-
-
0028954578
-
Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation
-
Jan-Feb;
-
Olivari MT, Jessen ME, Baldwin BJ, et al. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. J Heart Lung Transplant 1995 Jan-Feb; 14 (1 Pt 1): 127-35
-
(1995)
J Heart Lung Transplant
, vol.14
, Issue.1 PART 1
, pp. 127-135
-
-
Olivari, M.T.1
Jessen, M.E.2
Baldwin, B.J.3
-
120
-
-
20744457904
-
Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: The Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion
-
Jul;
-
White M, Haddad H, Leblanc MH, et al. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. J Heart Lung Transplant 2005 Jul; 24 (7): 798-809
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.7
, pp. 798-809
-
-
White, M.1
Haddad, H.2
Leblanc, M.H.3
-
121
-
-
1142286392
-
Bone loss after cardiac transplantation
-
Feb 19;
-
Lindsay R. Bone loss after cardiac transplantation. N Engl J Med 2004 Feb 19; 350 (8): 751-4
-
(2004)
N Engl J Med
, vol.350
, Issue.8
, pp. 751-754
-
-
Lindsay, R.1
-
122
-
-
0345435114
-
Progression of steroid-associated osteoporosis after heart transplantation
-
Jan;
-
Cremer J, Struber M, Wagenbreth I, et al. Progression of steroid-associated osteoporosis after heart transplantation. Ann Thorac Surg 1999 Jan; 67 (1): 130-3
-
(1999)
Ann Thorac Surg
, vol.67
, Issue.1
, pp. 130-133
-
-
Cremer, J.1
Struber, M.2
Wagenbreth, I.3
-
123
-
-
0037372164
-
Effects of cyclosporine on osteoclast activity: Inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activity
-
Mar;
-
Williams JP, McKenna MA, Thames AM, et al. Effects of cyclosporine on osteoclast activity: inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activity. J Bone Miner Res 2003 Mar; 18 (3): 451-7
-
(2003)
J Bone Miner Res
, vol.18
, Issue.3
, pp. 451-457
-
-
Williams, J.P.1
McKenna, M.A.2
Thames, A.M.3
-
124
-
-
0033819810
-
Bone loss after renal transplantation: Role of hyperparathyroidism, acidosis, cyclosporine and systemic disease
-
Oct;
-
Heaf J, Tvedegaard E, Kanstrup IL, et al. Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 2000 Oct; 14 (5): 457-63
-
(2000)
Clin Transplant
, vol.14
, Issue.5
, pp. 457-463
-
-
Heaf, J.1
Tvedegaard, E.2
Kanstrup, I.L.3
-
125
-
-
0030852304
-
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure
-
Sep;
-
Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997 Sep; 103 (3): 197-207
-
(1997)
Am J Med
, vol.103
, Issue.3
, pp. 197-207
-
-
Shane, E.1
Mancini, D.2
Aaronson, K.3
-
126
-
-
0037390157
-
Congestive heart failure is associated with the rate of bone loss
-
Apr;
-
Nishio K, Mukae S, Aoki S, et al. Congestive heart failure is associated with the rate of bone loss. J Intern Med 2003 Apr; 253 (4): 439-46
-
(2003)
J Intern Med
, vol.253
, Issue.4
, pp. 439-446
-
-
Nishio, K.1
Mukae, S.2
Aoki, S.3
-
127
-
-
0042666846
-
Pathogenesis of bone loss in heart transplant candidates and recipients
-
Aug;
-
Kerschan-Schindl K, Strametz-Juranek J, Heinze G, et al. Pathogenesis of bone loss in heart transplant candidates and recipients. J Heart Lung Transplant 2003 Aug; 22 (8): 843-50
-
(2003)
J Heart Lung Transplant
, vol.22
, Issue.8
, pp. 843-850
-
-
Kerschan-Schindl, K.1
Strametz-Juranek, J.2
Heinze, G.3
-
128
-
-
33644674991
-
Markers of bone metabolism in congestive heart failure
-
Apr;
-
Zittermann A, Schleithoff SS, Koerfer R. Markers of bone metabolism in congestive heart failure. Clin Chim Acta 2006 Apr; 366 (1-2): 27-36
-
(2006)
Clin Chim Acta
, vol.366
, Issue.1-2
, pp. 27-36
-
-
Zittermann, A.1
Schleithoff, S.S.2
Koerfer, R.3
-
129
-
-
33646766103
-
Comparison of calcitonin versus calcitonin + resistance exercise as prophylaxis for osteoporosis in heart transplant recipients
-
Apr 27;
-
Braith RW, Magyari PM, Fulton MN, et al. Comparison of calcitonin versus calcitonin + resistance exercise as prophylaxis for osteoporosis in heart transplant recipients. Transplantation 2006 Apr 27; 81 (8): 1191-5
-
(2006)
Transplantation
, vol.81
, Issue.8
, pp. 1191-1195
-
-
Braith, R.W.1
Magyari, P.M.2
Fulton, M.N.3
-
130
-
-
22744458717
-
Bisphosphonates routine in prevention of post-transplant osteoporosis? [letter]
-
Aug;
-
Hofle G, Holzmuller H, Drexel H. Bisphosphonates routine in prevention of post-transplant osteoporosis? [letter]. J Bone Miner Res 2005 Aug; 20 (8): 1482
-
(2005)
J Bone Miner Res
, vol.20
, Issue.8
, pp. 1482
-
-
Hofle, G.1
Holzmuller, H.2
Drexel, H.3
-
131
-
-
19044362279
-
Heart transplant recipient clinical profile improvement following mycophenolate mofetil late incorporation into the treatment schedule
-
Jun;
-
Manito N, Kaplinsky EJ, Roca J, et al. Heart transplant recipient clinical profile improvement following mycophenolate mofetil late incorporation into the treatment schedule. Clin Transplant 2005 Jun; 19 (3): 304-8
-
(2005)
Clin Transplant
, vol.19
, Issue.3
, pp. 304-308
-
-
Manito, N.1
Kaplinsky, E.J.2
Roca, J.3
-
132
-
-
0036435748
-
The impact of diabetes mellitus at the time of heart transplantation on long-term survival
-
Nov;
-
Czerny M, Sahin V, Fasching P, et al. The impact of diabetes mellitus at the time of heart transplantation on long-term survival. Diabetologia 2002 Nov; 45 (11): 1498-508
-
(2002)
Diabetologia
, vol.45
, Issue.11
, pp. 1498-1508
-
-
Czerny, M.1
Sahin, V.2
Fasching, P.3
-
133
-
-
2342427572
-
Heart transplantation in diabetic recipients: A decade review of 161 patients at Columbia Presbyterian
-
May;
-
Morgan JA, John R, Weinberg AD, et al. Heart transplantation in diabetic recipients: a decade review of 161 patients at Columbia Presbyterian. J Thorac Cardiovasc Surg 2004 May; 127 (5): 1486-92
-
(2004)
J Thorac Cardiovasc Surg
, vol.127
, Issue.5
, pp. 1486-1492
-
-
Morgan, J.A.1
John, R.2
Weinberg, A.D.3
-
134
-
-
33751249907
-
Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: An analysis of the United Network of Organ Sharing database
-
Nov 21;
-
Russo MJ, Chen JM, Hong KN, et al. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation 2006 Nov 21; 114 (21): 2280-7
-
(2006)
Circulation
, vol.114
, Issue.21
, pp. 2280-2287
-
-
Russo, M.J.1
Chen, J.M.2
Hong, K.N.3
-
135
-
-
0033983666
-
Predicting the occurrence of diabetes mellitus in recipients of heart transplants
-
Jan;
-
Depczynski B, Daly B, Campbell LV, et al. Predicting the occurrence of diabetes mellitus in recipients of heart transplants. Diabet Med 2000 Jan; 17 (1): 15-9
-
(2000)
Diabet Med
, vol.17
, Issue.1
, pp. 15-19
-
-
Depczynski, B.1
Daly, B.2
Campbell, L.V.3
-
136
-
-
21244500992
-
Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: Clinical and neurohormonal benefits
-
Dec;
-
Mehra MR, Uber PA, Park MH, et al. Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits. Transplant Proc 2004 Dec; 36 (10): 3152-5
-
(2004)
Transplant Proc
, vol.36
, Issue.10
, pp. 3152-3155
-
-
Mehra, M.R.1
Uber, P.A.2
Park, M.H.3
-
137
-
-
0035993711
-
Tacrolimus and new onset diabetes mellitus: The effect of steroid weaning
-
Aug;
-
Baran DA, Ashkar J, Galin ID, et al. Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning. Transplant Proc 2002 Aug; 34 (5): 1711-2
-
(2002)
Transplant Proc
, vol.34
, Issue.5
, pp. 1711-1712
-
-
Baran, D.A.1
Ashkar, J.2
Galin, I.D.3
-
138
-
-
0042360213
-
Chronic renal failure after transplantation of a nonrenal organ
-
Sep 4;
-
Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003 Sep 4; 349 (10): 931-40
-
(2003)
N Engl J Med
, vol.349
, Issue.10
, pp. 931-940
-
-
Ojo, A.O.1
Held, P.J.2
Port, F.K.3
-
139
-
-
0029987555
-
Insights into chronic cyclosporine nephrotoxicity
-
Bennett WM. Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther 1996; 34: 515-9
-
(1996)
Int J Clin Pharmacol Ther
, vol.34
, pp. 515-519
-
-
Bennett, W.M.1
-
140
-
-
0029806297
-
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
-
Bennett WM, DeMattos A, Meyer MM, et al. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996; 50: 1089-100
-
(1996)
Kidney Int
, vol.50
, pp. 1089-1100
-
-
Bennett, W.M.1
DeMattos, A.2
Meyer, M.M.3
-
142
-
-
0028861626
-
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: Preliminary results from US Multicenter trial
-
Porayko MK, Gonwa TA, Klintmalm GB, et al. Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. Transplant Proc 1995; 27: 1114-6
-
(1995)
Transplant Proc
, vol.27
, pp. 1114-1116
-
-
Porayko, M.K.1
Gonwa, T.A.2
Klintmalm, G.B.3
-
143
-
-
0028046793
-
A prospective study of renal structure and function in psoriasis patients treated with cyclosporin
-
Young EW, Ellis CN, Messana JM, et al. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin. Kidney Int 1994; 46: 1216-22
-
(1994)
Kidney Int
, vol.46
, pp. 1216-1222
-
-
Young, E.W.1
Ellis, C.N.2
Messana, J.M.3
-
144
-
-
0026808461
-
The pathologic changes in long-term heart and lung transplant survivors
-
Jul-Aug;
-
Billingham ME. The pathologic changes in long-term heart and lung transplant survivors. J Heart Lung Transplant 1992 Jul-Aug; 11 (4 Pt 2): S252-7
-
(1992)
J Heart Lung Transplant
, vol.11
, Issue.4 PART 2
-
-
Billingham, M.E.1
-
145
-
-
0034466751
-
What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
-
Kobashigawa JA. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy? Curr Control Trials Cardiovasc Med 2000; 1: 166-71
-
(2000)
Curr Control Trials Cardiovasc Med
, vol.1
, pp. 166-171
-
-
Kobashigawa, J.A.1
-
146
-
-
20944441873
-
Multicenter intravascular ultrasound validation study among heart transplant recipients: Outcomes after five years
-
Kobashigawa JA, Tobis JM, Starling RC, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol 2005; 45 (9): 1532-7
-
(2005)
J Am Coll Cardiol
, vol.45
, Issue.9
, pp. 1532-1537
-
-
Kobashigawa, J.A.1
Tobis, J.M.2
Starling, R.C.3
-
147
-
-
16244406560
-
Improving outcomes in heart transplantation: The potential of proliferation signal inhibitors
-
Eisen H, Kobashigawa J, Starling RC, et al. Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. Transplant Proc 2005; 37 (4 Suppl.): 4-17S
-
(2005)
Transplant Proc
, vol.37
, Issue.4 SUPPL.
-
-
Eisen, H.1
Kobashigawa, J.2
Starling, R.C.3
-
148
-
-
33646095991
-
Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model
-
Apr;
-
Beiras-Fernandez A, Chappell D, Hammer C, et al. Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model. Transpl Immunol 2006 Apr; 15 (4): 273-9
-
(2006)
Transpl Immunol
, vol.15
, Issue.4
, pp. 273-279
-
-
Beiras-Fernandez, A.1
Chappell, D.2
Hammer, C.3
-
149
-
-
33644616283
-
In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model
-
Feb 27;
-
Chappell D, Beiras-Fernandez A, Hammer C, et al. In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model. Transplantation 2006 Feb 27; 81 (4): 552-8
-
(2006)
Transplantation
, vol.81
, Issue.4
, pp. 552-558
-
-
Chappell, D.1
Beiras-Fernandez, A.2
Hammer, C.3
-
150
-
-
33750343813
-
Case report: Long-term outcome of a heart transplant recipient switched to everolimus after an acute myocardial infarction
-
Oct 27;
-
Frigerio M, Cipriani MG, Roubina E, et al. Case report: long-term outcome of a heart transplant recipient switched to everolimus after an acute myocardial infarction. Transplantation 2006 Oct 27; 82 (8 Suppl.): S19-23
-
(2006)
Transplantation
, vol.82
, Issue.8 SUPPL.
-
-
Frigerio, M.1
Cipriani, M.G.2
Roubina, E.3
-
151
-
-
1942476133
-
Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients
-
Ulrich C, Schmook T, Sachse MM, et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30 (4 Pt 2): 622-7
-
(2004)
Dermatol Surg
, vol.30
, Issue.4 PART 2
, pp. 622-627
-
-
Ulrich, C.1
Schmook, T.2
Sachse, M.M.3
-
152
-
-
2942587074
-
Cancer after kidney transplantation in the United States
-
Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4 (6): 905-13
-
(2004)
Am J Transplant
, vol.4
, Issue.6
, pp. 905-913
-
-
Kasiske, B.L.1
Snyder, J.J.2
Gilbertson, D.T.3
-
153
-
-
33645458234
-
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
-
Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17 (2): 581-9
-
(2006)
J Am Soc Nephrol
, vol.17
, Issue.2
, pp. 581-589
-
-
Campistol, J.M.1
Eris, J.2
Oberbauer, R.3
-
154
-
-
27644436740
-
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
-
Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005; 80 (7): 883-9
-
(2005)
Transplantation
, vol.80
, Issue.7
, pp. 883-889
-
-
Kauffman, H.M.1
Cherikh, W.S.2
Cheng, Y.3
-
155
-
-
33745787242
-
Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients
-
Andres V, Castro C, Campistol JM. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients. Nephrol Dial Transplant 2006; 21 Suppl. 3: iii14-7
-
(2006)
Nephrol Dial Transplant
, vol.21
, Issue.SUPPL. 3
-
-
Andres, V.1
Castro, C.2
Campistol, J.M.3
-
156
-
-
29544442185
-
Everolimus (Certican®) in heart transplantation: Optimizing renal function through minimizing cyclosporine exposure
-
Dec;
-
Lehmkuhl H, Ross H, Eisen H, et al. Everolimus (Certican®) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure. Transplant Proc 2005 Dec; 37 (10): 4145-9
-
(2005)
Transplant Proc
, vol.37
, Issue.10
, pp. 4145-4149
-
-
Lehmkuhl, H.1
Ross, H.2
Eisen, H.3
-
157
-
-
24044443235
-
Pharmacokinetic considerations relating to tacrolimus dosing in the elderly
-
Staatz CE, Tett SE. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs Aging 2005; 22 (5): 541-57
-
(2005)
Drugs Aging
, vol.22
, Issue.5
, pp. 541-557
-
-
Staatz, C.E.1
Tett, S.E.2
-
158
-
-
1942458255
-
Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences to tissue dosimetry
-
Clevell H, Gentry P, Covington TR, et al. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences to tissue dosimetry. Toxicol Sci 2004; 79: 381-93
-
(2004)
Toxicol Sci
, vol.79
, pp. 381-393
-
-
Clevell, H.1
Gentry, P.2
Covington, T.R.3
-
159
-
-
0012642273
-
Pharmacokinetics
-
Crome P, Ford G, editors, London: Imperial College Press
-
O'Mahoney S. Pharmacokinetics. In: Crome P, Ford G, editors. Drugs and the older population. London: Imperial College Press, 2000: 58-89
-
(2000)
Drugs and the older population
, pp. 58-89
-
-
O'Mahoney, S.1
-
160
-
-
33748057835
-
An up-date review on individualized dosage adjustments of calcineurin inhibitors in organ transplant patients
-
Masuda S, Inui KI. An up-date review on individualized dosage adjustments of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 2006; 112: 184-98
-
(2006)
Pharmacol Ther
, vol.112
, pp. 184-198
-
-
Masuda, S.1
Inui, K.I.2
-
161
-
-
0242334031
-
Drug therapy in the elderly
-
Noble RE. Drug therapy in the elderly. Metabolism 2003; 52 (10 Suppl. 2): 27-30
-
(2003)
Metabolism
, vol.52
, Issue.10 SUPPL. 2
, pp. 27-30
-
-
Noble, R.E.1
|